https://www.selleckchem.com/pr....oducts/phosphoramido
We propose that inhibition of CRLF1 is a potential therapeutic strategy to treat HLF.X-linked hypophosphatemia (XLH) is characterized by rickets and osteomalacia, caused by inactivating mutations in the Phosphate-regulating endopeptidase homolog X-linked (PHEX) gene. With aging, adult patients develop paradoxical heterotopic calcifications of tendons and ligaments at their insertion sites (enthesophytes), and joint alterations. Understanding the progression of this structural damage that severely affects patients' q
Like
Comment
Share
